Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Background

A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 7 PhD students to completion, and is currently an advisor to 2 PhD students.

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc command.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Not available for supervision

Fields of research

Biomedical and Clinical Sciences Biostatistics Health Sciences Mathematical Sciences Statistics

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Clinical trials

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes considered, significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations and the anticipated width of 95% confidence intervals.

  • Meta-analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. He advocates for the reporting of tau (or exp(tau) for ratios) rather than tau^2 as it better facilitates understanding of heterogeneity estimates.

Search Professor Mark Chatfield’s works on UQ eSpace

279 works between 2004 and 2026
All (279) Journal Article (215) Conference Publication (63) Book Chapter (1)

21 - 40 of 279 works

2024

Journal Article

Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes

Wen, Sophie C. H., Harris, Patrick N. A., Forde, Brian, Permana, Budi, Chatfield, Mark D., Lau, Colleen L., Spurling, Geoffrey, Bauer, Michelle J., Balch, Ross, Chambers, Henry, Schlapbach, Luregn J., Clark, Julia E., Dougherty, Sonia, Blyth, Christopher C., Britton, Philip N., Clifford, Vanessa, Haeusler, Gabrielle M., McMullan, Brendan, Wadia, Ushma, Paterson, David L., Irwin, Adam D., on behalf of the PAEDS network, Carr, Jeremy, Vasilunas, Nan, Francis, Joshua R., Macartney, Kristine, Crawford, Nigel W., Wood, Nicholas, Buttery, Jim ... Glover, Catherine (2024). Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes. Clinical Infectious Diseases, 79 (3), 734-743. doi: 10.1093/cid/ciae341

Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes

2024

Journal Article

Integrating omics techniques and culture-independent systems may improve the detection of persistent candidemia: data from an observational study

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Bergh, Haakon, Tabah, Alexis, Chatfield, Mark D, Harris, Patrick NA and Paterson, David L (2024). Integrating omics techniques and culture-independent systems may improve the detection of persistent candidemia: data from an observational study. Annals of Clinical Microbiology and Antimicrobials, 23 (1) 75, 75. doi: 10.1186/s12941-024-00736-w

Integrating omics techniques and culture-independent systems may improve the detection of persistent candidemia: data from an observational study

2024

Journal Article

Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis

Peri, Anna Maria, Chatfield, Mark D., Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A. and Paterson, David L. (2024). Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clinical Infectious Diseases, 79 (2), 502-515. doi: 10.1093/cid/ciae234

Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis

2024

Journal Article

Sensitivity and specificity of the Neonatal Visual Assessment to predict motor and cognitive outcomes in infants born very preterm

Blazek, Jessica W., Colditz, Paul B., Guzzetta, Andrea, Ware, Robert S., Chatfield, Mark D., Hough, Judith L., Boyd, Roslyn N. and George, Joanne M. (2024). Sensitivity and specificity of the Neonatal Visual Assessment to predict motor and cognitive outcomes in infants born very preterm. Early Human Development, 195 106068, 1-9. doi: 10.1016/j.earlhumdev.2024.106068

Sensitivity and specificity of the Neonatal Visual Assessment to predict motor and cognitive outcomes in infants born very preterm

2024

Journal Article

Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?

Dorofaeff, Tavey, Valero, Yarmarly Guerra, Coulthard, Mark G., Wallis, Steven C., Chatfield, Mark D., Lister, Paula, Lipman, Jeffrey, Roberts, Jason A. and Parker, Suzanne L. (2024). Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?. Bioanalysis, 16 (16), 873-881. doi: 10.1080/17576180.2024.2377912

Can capillary microsampling facilitate a clinical pharmacokinetics study of cefazolin in critically ill children?

2024

Conference Publication

Efficacy of upper limb therapies for children with cerebral palsy: Systematic review and network meta-analysis

Burgess, A., Chatfield, M., Jackman, M., Thorley, M., Reedman, S., Boyd, R. and Sakzewski, L. (2024). Efficacy of upper limb therapies for children with cerebral palsy: Systematic review and network meta-analysis. 12th AusACPDM Biennial Conference, Cairns, QLD Australia, 31 July - 3 August 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Efficacy of upper limb therapies for children with cerebral palsy: Systematic review and network meta-analysis

2024

Journal Article

The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia

Gassiep, Ian, Chatfield, Mark D., Permana, Budi, Burnard, Delaney, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Mayer-Coverdale, Johanna, Norton, Robert E. and Harris, Patrick N. A. (2024). The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia. Pathogens, 13 (7) 584, 584. doi: 10.3390/pathogens13070584

The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia

2024

Journal Article

Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA

Martin-Khan, Melinda G., Gray, Leonard C., Brand, Caroline, Wright, Olivia, Pachana, Nancy A., Byrne, Gerard J., Chatfield, Mark D., Jones, Richard, Morris, John, Travers, Catherine, Tropea, Joanne, Xiong, Beibei, Research Collaborative for Quality Care: Acute Care Panel and Research Collaborative for Quality Care: Dementia Care Panel (2024). Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA. BMC Geriatrics, 24 (1) 527, 1-13. doi: 10.1186/s12877-024-04980-9

Patient outcome quality indicators for older persons in acute care: original development data using interRAI AC-CGA

2024

Journal Article

Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial

Petersiel, Neta, Giulieri, Stefano, Daniel, Diane S., Fan, Sook-Ha, Ersoy, Selvi C., Davis, Joshua S., Bayer, Arnold S., Howden, Benjamin P., Tong, Steven Y. C., Lye, David C., Yahav, Dafna, Sud, Archana, Robinson, J. Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A., Cass, Alan, Paterson, David L., Foo, Hong, Paul, Mical, Guy, Stephen D., Tramontana, Adrian R., Walls, Genevieve B., McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A., Ralph, Anna P., Davies, Jane ... on behalf of the CAMERA2 study group (2024). Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial Agents and Chemotherapy, 68 (7) e0021824, 1-15. doi: 10.1128/aac.00218-24

Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO 3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial

2024

Journal Article

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Leach, Amanda Jane, Wilson, Nicole, Arrowsmith, Beth, Beissbarth, Jemima, Mulholland, Kim, Santosham, Mathuram, Torzillo, Paul John, McIntyre, Peter, Smith-Vaughan, Heidi, Skull, Sue A., Oguoma, Victor M., Chatfield, Mark D., Lehmann, Deborah, Brennan-Jones, Christopher G., Binks, Michael J., Licciardi, Paul V., Andrews, Ross M., Snelling, Tom, Krause, Vicki, Carapetis, Jonathan, Chang, Anne B. and Morris, Peter Stanley (2024). Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules. PLoS Medicine, 21 (6) e1004375, 1-15. doi: 10.1371/journal.pmed.1004375

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

2024

Conference Publication

Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project

Au, T., Beattie, E., Bennett, S., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Comans, T., Dissanayaka, N., Guy, R., Keramat, S.A., King, T., Lehn, A., Liddle, J., Mitchell, L., Oram, J., O’Sullivan, J., Pacas Fronza, G., Pachana, N., Pietsch, A., Tan, J., Welsh, K. and Worthy, P. (2024). Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024.

Technology assisted and remotely delivered anxiety psychotherapy intervention for people living with dementia and their care partners: Tech-CBT project

2024

Conference Publication

Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project

Au, T., Bailey, D., Beattie, E., Brooks, D., Broome, A., Byrne, G., Chatfield, M., Dissanayaka, N., Keramat, S.A., Lehn, A., Liddle, J., Marsh, R., Mitchell, L., Naismith, S., Nestor, S., O’Sullivan, J., Pachana, N., Pourzinal, D., Robertson, S., Shrubsole, K., Sivakumaran, K., Spooner, D., Tinson, H., Verreynne, M.L., Worthy, P. and Yang, J. (2024). Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project. Australian Dementia Research Forum 2024, Gold Coast, QLD Australia, 3-5 June 2024.

Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson’s disease: PDCogniCare project

2024

Journal Article

The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy

Hatton, Anna L., Chatfield, Mark D., Cattagni, Thomas and Vicenzino, Bill (2024). The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy. Gait and Posture, 111, 8-13. doi: 10.1016/j.gaitpost.2024.04.008

The effects of vibrating shoe insoles on standing balance, walking, and ankle-foot muscle activity in adults with diabetic peripheral neuropathy

2024

Conference Publication

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

Burgess, A., Chatfield, M., Jackman, M., Thorley, M., Reedman, S., Patel, M., Boyd, R.N. and Sakzewski, L. (2024). Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.. European Academy of Childhood Disabilty, Bruges, Belgium, 29 May-1 June 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Efficacy of upper limb therapies for children with cerebral palsy: systematic review and network meta-analysis.

2024

Journal Article

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

Collaro, Andrew J., Foong, Rachel, Chang, Anne B., Marchant, Julie M., Blake, Tamara L., Cole, Johanna F., Pearson, Glenn, Hii, Rebecca, Brown, Henry, Chatfield, Mark D., Hall, Graham and McElrea, Margaret S. (2024). Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study. Medical Journal of Australia, 220 (10), 523-529. doi: 10.5694/mja2.52306

Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross‐sectional study

2024

Journal Article

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

Chang, Anne B., Yerkovich, Stephanie T., Baines, Katherine J., Burr, Lucy, Champion, Anita, Chatfield, Mark D., Eg, Kah P, Goyal, Vikas, Marsh, Robyn L, McCallum, Gabrielle B, McElrea, Margaret, McPhail, Steven, Morgan, Lucy C, Morris, Peter S, Nathan, Anne M, O’Farrell, Hannah, Sanchez, Marion O, Parsons, Marianne, Schultz, André, Torzillo, Paul J, West, Nicholas P, Versteegh, Lesley, Marchant, Julie M and Grimwood, Keith (2024). Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respiratory Research, 11 (1) e002216, e002216. doi: 10.1136/bmjresp-2023-002216

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

2024

Journal Article

Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach

Petersiel, Neta, Davis, Joshua S., Meagher, Niamh, Price, David J., Tong, Steven Y. C., Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA2) Study Group, Lye, David C., Yahav, Dafna, Sud, Archana, Robinson, J. Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A., Cass, Alan, Paterson, David L., Foo, Hong, Paul, Mical, Guy, Stephen D., Tramontana, Adrian R., Walls, Genevieve B., McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A., Ralph, Anna P., Davies, Jane, Ferguson, Patricia E., Dotel, Ravindra, McKew, Genevieve L. ... Sullivan, Matthew V. N. O. (2024). Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach. Open Forum Infectious Diseases, 11 (5) ofae181. doi: 10.1093/ofid/ofae181

Combination of antistaphylococcal β-lactam with standard therapy compared to standard therapy alone for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a post hoc analysis of the CAMERA2 trial using a desirability of outcome ranking approach

2024

Journal Article

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D., Harris, Patrick N.A. and Paterson, David L. (2024). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases, 78 (2), 283-291. doi: 10.1093/cid/ciad663

Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications

2024

Journal Article

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

Hardy, Melissa, Harris, Patrick N. A., Paterson, David L., Chatfield, Mark D., Mo, Yin, for the MERINO trial investigators, Tambyah, Paul A., Lye, David C., Lee, Tau H., Yilmaz, Mesut, Alenazi, Thamer H., Arabi, Yaseen, Falcone, Marco, Bassetti, Matteo, Righi, Elda, Rogers, Benjamin A., Kanj, Souha, Bhally, Hasan, Iredell, Jon, Mendelson, Marc, Boyles, Tom H., Looke, David, Miyakis, Spiros, Walls, Genevieve, Al Khamis, Mohammed, Zikri, Ahmed, Crowe, Amy, Ingram, Paul, Daneman, Nick ... Peleg, Anton Y. (2024). Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial. Clinical Infectious Diseases, 78 (6), 1482-1489. doi: 10.1093/cid/ciae050

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial

2024

Conference Publication

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Mayer-Coverdale, Johanna, Norton, Robert and Harris, Patrick N.A. (2024). The molecular epidemiology of Burkholderia pseudomallei in North Queensland. Pathology Update 2024, Adelaide, VIC, Australia, 1 - 3 March 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2023.12.133

The molecular epidemiology of Burkholderia pseudomallei in North Queensland

Current funding

  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2028
    The clinical and cost effectiveness of the Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors (The FISS-AUSTRALIA trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2024 - 2027
    Losing touch: Exploring the neurophysiological effects of bionic sensory insole technology for balance rehabilitation
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2026
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2027
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2026
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Availability

Mr Mark Chatfield is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au